Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$0.28 - $1.16 $5,600 - $23,200
20,000 Added 4878.05%
20,410 $6,000
Q1 2024

May 14, 2024

BUY
$1.06 - $1.67 $116 - $183
110 Added 36.67%
410 $0
Q3 2023

Nov 13, 2023

SELL
$1.61 - $2.54 $3,744 - $5,908
-2,326 Reduced 88.58%
300 $0
Q3 2023

Nov 07, 2023

BUY
$1.61 - $2.54 $3,825 - $6,035
2,376 Added 950.4%
2,626 $4,000
Q2 2023

Aug 07, 2023

SELL
$1.14 - $1.95 $2,166 - $3,705
-1,900 Reduced 88.37%
250 $0
Q1 2022

May 04, 2022

BUY
$2.83 - $8.69 $6,084 - $18,683
2,150 New
2,150 $9,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.6B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.